Anurag Saraf
Overview
Explore the profile of Anurag Saraf including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
232
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Saraf A, He J, Shin K, Weiss J, Awad M, Gainor J, et al.
Clin Lung Cancer
. 2025 Feb;
PMID: 39986945
Introduction: Sarcopenia is associated with worse survival in non-small cell lung cancer (NSCLC), but less studied in association with toxicity. Here, we investigated the association between imaging-assessed sarcopenia with toxicity...
2.
Sentana-Lledo D, Saraf A, Morgans A
J Natl Compr Canc Netw
. 2024 Dec;
23(1.
PMID: 39705803
Prostate cancer survivors represent a growing population of patients with a diagnosis of prostate cancer, whether they were cured using local therapies or continue to receive systemic treatment of advanced...
3.
Thompson L, Florissi C, Yoon J, Singh A, Saraf A
Cancers (Basel)
. 2024 Nov;
16(22).
PMID: 39594755
Older adults with lung cancer experience inferior clinical outcomes compared to their younger counterparts. This review provides the scaffolding to address these disparities by delineating (1) the distinct and varied...
4.
Jarnagin J, Saraf A, Baiev I, Chi G, Van Seventer E, Mojtahed A, et al.
JAMA Netw Open
. 2023 Nov;
6(11):e2343512.
PMID: 37976066
Importance: Patient-reported outcomes (PROs), such as quality of life (QOL) and symptoms, are often associated with clinical outcomes in patients with cancer. In practice, oncologists use serum tumor markers (TMs)...
5.
Zapaishchykova A, Liu K, Saraf A, Ye Z, Catalano P, Benitez V, et al.
Nat Commun
. 2023 Nov;
14(1):6863.
PMID: 37945573
Lean muscle mass (LMM) is an important aspect of human health. Temporalis muscle thickness is a promising LMM marker but has had limited utility due to its unknown normal growth...
6.
Ye Z, Saraf A, Ravipati Y, Hoebers F, Catalano P, Zha Y, et al.
JAMA Netw Open
. 2023 Aug;
6(8):e2328280.
PMID: 37561460
Importance: Sarcopenia is an established prognostic factor in patients with head and neck squamous cell carcinoma (HNSCC); the quantification of sarcopenia assessed by imaging is typically achieved through the skeletal...
7.
Saraf A, Tahir I, Hu B, Dietrich A, Tonnesen P, Sharp G, et al.
Int J Radiat Oncol Biol Phys
. 2023 Jul;
118(1):94-103.
PMID: 37506979
Purpose: Sarcopenia, an age-related decline in muscle mass and physical function, is associated with increased toxicity and worse outcomes in women with breast cancer (BC). Sarcopenia may contribute to toxicity-related...
8.
Ye Z, Saraf A, Ravipati Y, Hoebers F, Zha Y, Zapaishchykova A, et al.
medRxiv
. 2023 Mar;
PMID: 36945519
Purpose: Sarcopenia is an established prognostic factor in patients diagnosed with head and neck squamous cell carcinoma (HNSCC). The quantification of sarcopenia assessed by imaging is typically achieved through the...
9.
Saraf A, Roberts H, Wo J, Parikh A
J Natl Compr Canc Netw
. 2022 Oct;
20(10):1177-1184.
PMID: 36240854
Neoadjuvant therapy is standard of care for locally advanced rectal cancer (LARC). Advancements in multimodality therapy options and sequencing of radiation therapy (RT), surgery, and chemotherapy make decision-making challenging. Traditional...
10.
Plana D, Shung D, Grimshaw A, Saraf A, Sung J, Kann B
JAMA Netw Open
. 2022 Sep;
5(9):e2233946.
PMID: 36173632
Importance: Despite the potential of machine learning to improve multiple aspects of patient care, barriers to clinical adoption remain. Randomized clinical trials (RCTs) are often a prerequisite to large-scale clinical...